Oncolytic Virus Therapies Market Report by Virus Type (Genetically Engineered Oncolytic Viruses, Oncolytic Wild-Type Viruses), Application (Solid Tumors, Melanoma), End Use (Hospitals, Specialty Clinics, Cancer Research Institute), and Region 2025-2033

Oncolytic Virus Therapies Market Report by Virus Type (Genetically Engineered Oncolytic Viruses, Oncolytic Wild-Type Viruses), Application (Solid Tumors, Melanoma), End Use (Hospitals, Specialty Clinics, Cancer Research Institute), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A6592

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Oncolytic Virus Therapies Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Virus Type
    6.1    Genetically Engineered Oncolytic Viruses
        6.1.1 Market Trends
        6.1.2 Key Segments
           6.1.2.1 Herpes Simplex Virus
           6.1.2.2 Adenovirus
           6.1.2.3 Vaccinia Virus
        6.1.3 Market Forecast
    6.2    Oncolytic Wild-Type Viruses
        6.2.1 Market Trends
        6.2.2 Key Segments
           6.2.2.1 Reovirus
           6.2.2.2 Newcastle Disease Virus
           6.2.2.3 Vesicular Stomatitis Virus
        6.2.3 Market Forecast
7    Market Breakup by Application
    7.1    Solid Tumors
        7.1.1 Market Trends
        7.1.2 Key Segments
           7.1.2.1 Breast Cancer
           7.1.2.2 Prostate Cancer
           7.1.2.3 Lung Cancer
           7.1.2.4 Glioblastoma
        7.1.3 Market Forecast
    7.2    Melanoma
        7.2.1 Market Trends
        7.2.2 Key Segments
           7.2.2.1 Hematological Malignancies
           7.2.2.2 Lymphoma
           7.2.2.3 Leukemia
           7.2.2.4 Myeloma
        7.2.3 Market Forecast
8    Market Breakup by End Use
    8.1    Hospitals
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Specialty Clinics
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Cancer Research Institute
        8.3.1 Market Trends
        8.3.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
14    Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Amgen Inc. 
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
           14.3.1.4 SWOT Analysis
        14.3.2    Dnatrix Inc.
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
        14.3.3    Genelux Corporation
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
        14.3.4    Lokon Pharma AB
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
        14.3.5    Replimune Group Inc.
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
        14.3.6    Rigvir Ltd.
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
        14.3.7    Sorrento Therapeutics
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
           14.3.7.3 Financials
        14.3.8    Takara Bio Inc. (Takara Holdings Inc.)
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 Financials
        14.3.9    Targovax
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
        14.3.10    TILT Biotherapeutics Ltd
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
        14.3.11    Transgene SA
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio
           14.3.11.3 Financials
        14.3.12    Vyriad
           14.3.12.1 Company Overview
           14.3.12.2 Product Portfolio

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

​Figure 1: Global: Oncolytic Virus Therapies Market: Major Drivers and Challenges
Figure 2: Global: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019-2024
Figure 3: Global: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 4: Global: Oncolytic Virus Therapies Market: Breakup by Virus Type (in %), 2024
Figure 5: Global: Oncolytic Virus Therapies Market: Breakup by Application (in %), 2024
Figure 6: Global: Oncolytic Virus Therapies Market: Breakup by End Use (in %), 2024
Figure 7: Global: Oncolytic Virus Therapies Market: Breakup by Region (in %), 2024
Figure 8: Global: Oncolytic Virus Therapies (Genetically Engineered Oncolytic Viruses) Market: Sales Value (in Million USD), 2019 & 2024
Figure 9: Global: Oncolytic Virus Therapies (Genetically Engineered Oncolytic Viruses) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 10: Global: Oncolytic Virus Therapies (Oncolytic Wild-Type Viruses) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Oncolytic Virus Therapies (Oncolytic Wild-Type Viruses) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Oncolytic Virus Therapies (Solid Tumors) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Oncolytic Virus Therapies (Solid Tumors) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Oncolytic Virus Therapies (Melanoma) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Oncolytic Virus Therapies (Melanoma) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Oncolytic Virus Therapies (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Oncolytic Virus Therapies (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Oncolytic Virus Therapies (Specialty Clinics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Oncolytic Virus Therapies (Specialty Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Oncolytic Virus Therapies (Cancer Research Institute) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Oncolytic Virus Therapies (Cancer Research Institute) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: North America: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: North America: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: United States: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: United States: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: Canada: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: Canada: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: Asia-Pacific: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: Asia-Pacific: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: China: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: China: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: Japan: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: Japan: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: India: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: India: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: South Korea: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: South Korea: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: Australia: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: Australia: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: Indonesia: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: Indonesia: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: Others: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: Others: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: Europe: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: Europe: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: Germany: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: Germany: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: France: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: France: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: United Kingdom: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: United Kingdom: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: Italy: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: Italy: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: Spain: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: Spain: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: Russia: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: Russia: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: Others: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: Others: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: Latin America: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: Latin America: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: Brazil: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: Brazil: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: Mexico: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: Mexico: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: Others: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: Others: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: Middle East and Africa: Oncolytic Virus Therapies Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: Middle East and Africa: Oncolytic Virus Therapies Market: Breakup by Country (in %), 2024
Figure 70: Middle East and Africa: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: Global: Oncolytic Virus Therapies Industry: SWOT Analysis
Figure 72: Global: Oncolytic Virus Therapies Industry: Value Chain Analysis
Figure 73: Global: Oncolytic Virus Therapies Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Oncolytic Virus Therapies Market: Key Industry Highlights, 2024 & 2033
Table 2: Global: Oncolytic Virus Therapies Market Forecast: Breakup by Virus Type (in Million USD), 2025-2033
Table 3: Global: Oncolytic Virus Therapies Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 4: Global: Oncolytic Virus Therapies Market Forecast: Breakup by End Use (in Million USD), 2025-2033
Table 5: Global: Oncolytic Virus Therapies Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 6: Global: Oncolytic Virus Therapies Market: Competitive Structure
Table 7: Global: Oncolytic Virus Therapies Market: Key Players

Oncolytic Virus Therapies Market Report by Virus Type (Genetically Engineered Oncolytic Viruses, Oncolytic Wild-Type Viruses), Application (Solid Tumors, Melanoma), End Use (Hospitals, Specialty Clinics, Cancer Research Institute), and Region 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials